News
Although imatinib mesylate (IM) is highly effective at inducing complete cytogenetic remission in patients with chronic myelogenous leukemia (CML), it is known to suppress T-cell proliferation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results